NewsRx

Search our medical news database

Drug Development

Collin County, Texas Adopts Hythiam's PROMETA Treatment Program

Published in Drug Law Weekly, October 2nd, 2007

Hythiam, Inc. (NASDAQ:HYTM) announced the adoption of the PROMETA(R) Treatment Program for the treatment of the methamphetamine and cocaine dependent individuals within the probation, parole and re-entry programs in Collin County, Texas. This announcement follows the completion of a successful pilot evaluation within this felony-offender population. Participants in the pilot were the more difficult to treat, general felony offenders, and not those within an intensive, supervised drug court program. At a total population of about 500,000 people, Collin County has placed about 11,000 persons on probation alone in the past year, a large number of these sentencings attributed to drug-related...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook